Breast Cancer Risk from Radiotherapy
Author Information
Author(s): Uwe Schneider, Marcin Sumila, Judith Robotka, Günther Gruber, Andreas Mack, Jürgen Besserer
Primary Institution: Vetsuisse Faculty, University of Zürich
Hypothesis
What is the dose-response relationship for breast cancer induction after radiotherapy?
Conclusion
The study provides a dose-response relationship that can predict the risk of radiation-induced secondary breast cancer in patients undergoing radiotherapy.
Supporting Evidence
- The fitted model parameters for breast cancer risk were α = 0.067 Gy-1 and R = 0.62.
- The predicted excess absolute risk (EAR) for breast cancer after radiotherapy is 11.7/10000PY.
- The model predicts a 3.2-fold increased risk for mantle field irradiation compared to mediastinal irradiation.
Takeaway
This study helps us understand how radiation therapy can increase the risk of breast cancer, especially for women treated for Hodgkin's disease.
Methodology
The study used a dose-response model based on data from Hodgkin's disease patients and A-bomb survivors to predict breast cancer risk.
Potential Biases
The model does not include the impact of ovarian function on breast cancer induction, which could affect the results.
Limitations
The model assumes that age parameters can be applied uniformly across different dose categories, which may not account for individual variations.
Participant Demographics
The study analyzed a cohort of 3817 women treated for Hodgkin's disease, with a mean age at diagnosis of 22 years.
Statistical Information
P-Value
<0.01
Confidence Interval
95% CI: 6.8-12
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website